Ex-Valeant CEO's Pay Structure May Have Increased Dangerous Risk-Taking Study Says

J. Michael Pearson's tenure at Valeant Pharmaceuticals shows that even when all the right practices are followed, things can still go wrong.

via Forbes - Business